A teal bead-like signal beside a receptor-like form on an arched membrane.

Mechanisms & hormones

Glucose-dependent insulinotropic peptide (GIP)

Also found as: GIP · glucose-dependent insulinotropic peptide

In plain language

A peptide signal discussed in the tirzepatide paper in relation to its receptor and metabolic effects. Tirzepatide is described as acting at both GIP and GLP-1 receptors.[1]

Source check: 2026-10-04 · Editorial method

How the research uses this term

The paper discusses GIP receptor expression in adipose tissue and the possible relevance of receptor activation to lipid handling. Its own analysis measures circulating lipoprotein-related markers in trial participants.[1]

Reading the evidence

The authors use these measurements to investigate possible mechanisms behind lipid changes. That is a narrower question than directly measuring whether treatment prevents cardiovascular events.[1]

Used in our guides

Continue reading where this term appears.

References

Definitions and explanations are paraphrased. The source locations below identify the supporting passages and methods.

  1. The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetesPrimary research · Human trial biomarker analysis · 2020DOI: 10.1111/dom.14174

    Source locations: Introduction; Introduction; Materials and Methods; Aim and Discussion.

    Review status · Pending
    Source packet file

    The_dual_glucose_dependent_insulinotropic_peptide_and_glucagon_like_pept_33462955_PMC7756479.pdf